UBS O'Connor’s CME Group CME Stock Holding History

UBS O'Connor’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-21,800	Closed	-$12K	–	569
2015 Q2	$12K	Buy	+21,800	New	+$2.03M	﹤0.01%	763

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

UBS O'Connor's CME Position: Q1 2023 in Review

UBS O'Connor sold out of CME Group (CME) in Q1 2023, closing a stake of 16,000 shares — an estimated $2.69M sold.

UBS O'Connor first reported a position in CME in Q2 2015 and held it in 8 quarters. The position peaked at $5.49M in Q3 2015. 1,172 funds tracked by Wall St. Rank hold CME as of Q1 2023.

UBS O'Connor reported no remaining CME Group position as of Q1 2023 after selling out during the quarter.
UBS O'Connor sold 16,000 CME Group shares in Q1 2023, an estimated $2.69M.
UBS O'Connor first reported a position in CME Group in Q2 2015 and held it in 8 quarters.
UBS O'Connor's CME Group position peaked at $5.49M in Q3 2015.
1,172 funds tracked by Wall St. Rank held CME Group as of Q1 2023.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.